Kısraklarda yavru zarlarının atılamamasının sebepleri ve tedavisi

Yavru zarlarının atılamaması, kısrakların doğum sonrası problemlerinden biri olarak kabul edilir. Doğum sonrası üç saat içinde zarların tümü atılamamış ise, yavru zarlarının atılamaması olarak tanımlanmaktadır. Kısraklarda yavru zarlarının atılamama oranı %2-15 arasında değişmektedir. Yavru zarlarının atılamaması, doğum sonrası düşük oksitosin ve kalsiyum seviyesi, uterus durgunluğu, yavru zarlarının yangısı, histolojik bozukluklar ve güç doğum ile ilişkilidir. Yavru zarlarının atılamaması ile ilişkili komplikasyonlar; akut metritis, endometritis, fertilitide azalma, endotoksemi, septisemi, laminitis ve hatta ölüm olabilmektedir. Koruyucu tedavi (antibiyotik, nonsteroid antiinflamatuar ilaçlar, sıvı gibi), oksitosin tedavisi, korioallontoik boşluğa sıvı verilmesi, göbek kordonu arterleri yoluyla kollegenaz verilmesi ve zarların elle uzaklaştırılması şeklinde farklı tedavi seçenekleri bulunmaktadır. Bu derlemede, son literatürler ışığında kısraklarda yavru zarlarının atılamamasının sebepleri ve tedavisi değerlendirildi.

The causes and therapy of retained placenta in mares

Retained placenta is considered to be a problem in postpartum mares. Retained placenta was defined as a failure to expel all fetal membranes within 3 h of the delivery of the foal. The incidence of retained placenta in mares varies from 2% to 15% of foaling. Retained placenta was associated with lower postpartum oxytocin and calcium concentration, uterine inertia, placentitis, histological abnormalities, and dystocia. Complications of retained placenta include acute metritis, endometritis, reduction in fertility, endotoxemia, septicaemia, laminitis, and even death. Treatment options vary from conservative therapy (antibiotic, nonsteroid antiinflamatuar durugs, fluid etc), oxytocin therapy, infusion of fluids into the chorioallantoic space, injection of collagenases into the umbilical arteries, and manual removal of placenta. In this review, causes and treatment of retained placenta in mares were evaluated in the light of recent literature.

___

  • 1. Threlfall WR. Retained fetal membranes. In: Youngquist RS, Threlfall WR. (Editors). Current Therapy in Large Animal Theriogenology. 2th Edition, Philadelphia: Saunders 2007: 107-113.
  • 2. Paccamonti D, Pycock J. Infertility and subfertility in the mare. In: Noakes DE, Parkinson TJ, England GCW. (Editors). Veterinary Reproduction and Obstetrics. 9th Edition, Philadelphia: Saunders 2009: 582-631.
  • 3. Threlfall WR. Retained placenta. In: McKinnon AO, Voss JL. (Editors). Equine Reproduction. 1th Edition, Oxford: Blackwell 1993: 614-621.
  • 4. Cuervo-Arango J, Newcombe JR. The effect of manual removal of placenta ımmediately after foaling on subsequent fertility parameters in the mare. J Equine Vet Sci 2009; 29: 771-774.
  • 5. Blanchard TL, Macpherson ML. Postparturient abnormalities. In: Samper JC, Pycock J, McKinnon AO. (Editors). Current Therapy in Equine Reproduction, 2th Edition, Philadelphia: Saunders 2007: 465-475.
  • 6. Threlfall WR. Retained fetal membranes. In: Carleton CL. (Editor). Blackwell's Five-Minute Veterinary Consult Clinical Companion: Equine Theriogenology. 2th Edition, West Sussex: Willey-Blackwell 2011: 516-522
  • 7. Wessel M. Staging and prediction of parturition in the mare. Clin Tech in Equi Pract 2005; 4: 219-227.
  • 8. Frazer GS. Post partum complications in the mare. Part 2: Fetal membrane retention and conditions of the gastrointestinal tract, bladder and vagina. Equi Vet Educ 2003; 15: 91-100.
  • 9. Boerma S, Back W, Sloet van Oldruitenborgh-Oosterbaan MM. The Friesian horse breed: A clinical challenge to the equine veterinarian? Equi Vet Educ 2012; 24: 66-71.
  • 10. LeBlanc MM. Common peripartum problems in the mare. J Equine Vet Sci 2008; 28: 709-715.
  • 11. England GCW. Retained placenta. In: England GCW (Editor). Fertility and Obstetrics in the Horse. 3rd Edition, Oxford: Blackwell 2005: 173-177.
  • 12. Provencher R, Threlfall WR, Murdick PW, Wearly WK. Retained fetal membranes in the mare: a retrospective study. Can Vet J 1988; 29: 903-910.
  • 13. Alan M. Retentio secundinarum ve puerperal enfeksiyonlar. In: Alaçam E. (Editor). Evcil Hayvanlarda Doğum ve İnfertilite. 3th Edition, Ankara: Medisan 2002: 237-254.
  • 14. Ginther OJ, Williams D. On-the-farm incidence and nature of equine dystocias. J Equine Vet Sci 1996; 16: 159-164.
  • 15. Sevinga M, Barkema HW, Stryhn H, Hesselink JW. Retained placenta in Friesian mares: incidence, and potential risk factors with special emphasis on gestational length. Theriogenology 2004; 61: 851-859.
  • 16. Freeman DE, Hungerford LL, Schaeffer D, et al. Caesarean section and other methods for assisted delivery: comparison of effects on mare mortality and complications. Equi Vet J 1999; 31: 203-207.
  • 17. Monroe JL, Cross DL, Hudson LW, et al. Effect of selenium and endophyte-contaminated fescue on performance and reproduction in mares. J Equine Vet Sci 1988; 8: 148-153.
  • 18. Kahn W. Ultrasonography in the mare. In: Kahn W, Volkmann D, Kenney RM. (Editors). Veterinary Reproductive Ultrasonography. 1st Edition, Hannover: Mosby-Wolfe 1994: 11-82.
  • 19. Parsons CS, Orsini JA, Krafty R, Capewell L, Boston R. Risk factors for development of acute laminitis in horses during hospitalization: 73 cases (1997-2004). J Am Vet Med Assoc 2007; 230: 885-889.
  • 20. Sevinga M, Hesselink JW, Barkema HW. Reproductive performance of Friesian mares after retained placenta and manual removal of the pacenta. Theriogenology 2002; 57: 923-930.
  • 21. Ishii M, Shimamura T, Utsumi A, et al. Reproductive performance and factors that decrease pregnancy rate in heavy draft horses bred at the foal heat. J Equine Vet Sci 2001; 21: 131-136.
  • 22. Ishii M, Jitsukawa T, Shimamura T, et al. Effect of placental retention time and associated treatments on reproductive performance in heavy draft horses. J Equine Vet Sci 1999; 19: 117-121.
  • 23. Sevinga MM, Barkema HW, Hesselink JW. Serum calcium and magnesium concentrations and the use of a calciummagnesium- borogluconate solution in the treatment of Friesian mares with retained placenta. Theriogenology 2002; 57: 941-947.
  • 24. Ishii M, Ogato H, Shimizu H, et al. Effects of vitamin E and Selenıum administration on pregnant, heavy draft mares on placental retention time and reproductive performance and on white muscle disease in their foals. J Equine Vet Sci 2002; 22: 213-220.
  • 25. LeBlanc MM. Diseases involving the placenta. In: Colahan PT, Merritt AM, Moore JN, Mayhew IG. (Editors). Equine Medicine and Surgery. 5th Edition, St Louis: Mosby 1999: 1193-1199.
  • 26. Nimmo MR, Slone DE, Hughes FE, Lynch TM, Clark CK. Fertility and complications after fetotomy in 20 brood mares (2001-2006). Vet Surg 2007; 36: 771-774.
  • 27. Rapacz A, Pazdzior K, Ras A, Rotkiewicz T, Janowski TE. Retained fetal membranes in heavy draft mares associated with histological abnormalities. J Equine Vet Sci 2012; 32: 38-44.
  • 28. Pazdzior K, Rapacz A, Rotkiewicz T, Ras A. Proliferation and apoptosis in fetal membranes and endometrium during placental retention in heavy draft mares. J Equine Vet Sci 2012; 32: 80-84.
  • 29. Welle MM, Audigé L, Belz JP.The equine endometrial mast cell during the puerperal period: evaluation of mast cell numbers and types in comparison to other inflammatory changes. Vet Pathol 1997; 34: 23-30.
  • 30. Hudson NP, Prince DP, Mayhew IG, Watson ED. Investigation and management of a cluster of cases of equine retained fetal membranes in Highland Ponies. Vet Rec 2005; 157: 85-89.
  • 31. Berghuis GA, Wesselink HG. Treatment and gestation results of mares with secondary retention. Tijdschr Diergeneeskd 1995; 120: 300-301.
  • 32. Weems CW, Weems YS, Randel RD. Prostaglandins and reproduction in female farm animals. Vet J 2006: 171: 206- 228.
  • 33. Ishii M, Kobayashi S, Acosta TJ et al. Effective oxytocin treatment on placental expulsion after foaling in heavy draft mares. J Vet Med Sci 2009; 71: 293-297.
  • 34. Troedsson MH, Spensley MS, Fahning ML. Retained fetal membranes. In: Robinson NE (Editor). Current Therapy in Equine Medicine. 4th Edition, Philadelphia: Saunders 1997: 560-562.
  • 35. Card C, Lopate C. Infectious diseases of the puerperal period. In: Youngquist RS, Threlfall WR. (Editors). Current Therapy in Large Animal Theriogenology. 2th Edition, Philadelphia: Saunders 2007: 138-144.
  • 36. Haffner JC, Fecteau KA, Held JP, Eiler H. Equine retained placenta: technique for and tolerance to umbilical artery injections of collagenase. Theriogenology, 1998; 49: 711- 716.
  • 37. Fecteau KA, Haffner JC, Eiler H. The potential of collagenase as a new therapy for separation of human retained placenta: hydrolytic potency on human, equine and bovine placentae. Placenta 1998; 19: 379-383.
  • 38. Ingarden J, Dubiel A, Rauluszkiewicz S. The effect of administration of a beta blocker in periparturient mares. Equi Vet J Suppl 1998; 27: 19-20.
  • 39. Sevinga M, Vrijenhoek T, Hesselinks JW, Barkema HW, Groen AF. Effect of inbreeding on the incidence of retained placenta in Friesian horses. J Anim Sci 2004; 82: 982-986.